Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.86 USD | +0.44% | +3.48% | +3.82% |
May. 09 | RBC Lifts Price Target on Omega Healthcare Investors to $32 From $31, Keeps Sector Perform Rating | MT |
May. 03 | Transcript : Omega Healthcare Investors, Inc., Q1 2024 Earnings Call, May 03, 2024 |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- This company will be of major interest to investors in search of a high dividend stock.
- The opinion of analysts covering the stock has improved over the past four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- One of the major weak points of the company is its financial situation.
- With a 2024 P/E ratio at 23.64 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.82% | 7.84B | B | ||
+13.43% | 60.45B | A- | ||
-3.00% | 19.54B | A- | ||
-0.83% | 13.9B | A | ||
-7.31% | 6.05B | B- | ||
+14.28% | 3.64B | C- | ||
+0.95% | 3.33B | C+ | ||
-4.40% | 3.09B | B+ | ||
+1.12% | 3B | C | ||
+17.74% | 2.86B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- OHI Stock
- Ratings Omega Healthcare Investors, Inc.